Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Pharmaceutical giant Eli Lilly has partnered with AbCellera Biologics, a biotechnology company based in Canada, to address the new coronavirus crisis by developing antibody products to treat and prevent the virus.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health have begun a Phase 1 clinical trial for a vaccine to protect against the new coronavirus, COVID-19.
One algorithmic approach used to model and analyze complex networks is fundamentally flawed and fails to capture the full properties of real-world complexities, according to a new study published in Proceedings of the National Academy of Sciences.
As the U.S. continues ramping up its response to the new coronavirus, COVID-19, the role of AI could loom large in helping identify the highest risk patients.
Researchers have located the part of the brain that causes pediatric patients to stop breathing during a seizure, sharing their findings in JCI Insight.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.